Nanovi A/S is a Danish medical device company. We specialize in the development and commercialization of innovative liquid fiducial markers.
Our dedication is to enable high precision in image guided radiotherapy and cancer surgery to benefit patients and society.
We have a product portfolio and development pipeline of liquid fiducial markers for both human and veterinary use. Our lead product for human use, BioXmark®, is a liquid fiducial marker that enables high precision image guided radiotherapy. BioXmark® is expected to be CE marked in 2019.
Nanovi is founded on a patented technology platform for medical applications, co-invented with the Technical University of Denmark, DTU.
The company is located north of Copenhagen, Denmark.
Nanovi was founded in 2012 with the aim of raising radiotherapy standards without changing current routines and equipment. The idea arose from a real medical need for better guidance of radiation treatment, which the founders believed could be solved by advanced biomaterials.